Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123282
Filing Date
2024-11-07
Accepted
2024-11-07 16:05:35
Documents
58
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gern-20240930.htm   iXBRL 10-Q 2620693
2 EX-10.1 gern-ex10_1.htm EX-10.1 114556
3 EX-31.1 gern-ex31_1.htm EX-31.1 15875
4 EX-31.2 gern-ex31_2.htm EX-31.2 15904
5 EX-32.1 gern-ex32_1.htm EX-32.1 8529
6 EX-32.2 gern-ex32_2.htm EX-32.2 8385
  Complete submission text file 0000950170-24-123282.txt   9343858

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT gern-20240930.xsd EX-101.SCH 1165388
61 EXTRACTED XBRL INSTANCE DOCUMENT gern-20240930_htm.xml XML 1674776
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 241435523
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)